(Q81301426)
Statements
Postwithdrawal rebound increase in T2 lesional activity in natalizumab-treated MS patients (English)
Vellinga MM
Castelijns JA
Barkhof F
Uitdehaag BM
13 September 2007
scientific article published on 13 September 2007